Shanghai Shyndec Pharmaceutical gets approval for new drug clinical trial

Thursday, May 11, 2017

Shanghai Shyndec Pharmaceutical Co Ltd Says the co received approval from China Food and Drug Administration to start new drug clinical trial for a kind of modified release capsule.

The modified release capsule is antidepressant used for treatment of decreased attention, fatigue and sluggish.

The co will be able to sell modified release capsule after getting approval from China Food and Drug Administration.



Other News